Cargando…
Human hybridomas from patients with malignant disease.
Lymphocytes from 180 patients with a variety of malignant diseases were collected and fused with a human myeloma-derived line, LON-LICR-HMy2/CAM1. A total of 162 hybridomas was obtained. Only B lymphocyte markers were found on the surface of the fusion products. Flow cytometric analysis revealed a s...
Autores principales: | Sikora, K., Alderson, T., Ellis, J., Phillips, J., Watson, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011244/ https://www.ncbi.nlm.nih.gov/pubmed/6336943 |
Ejemplares similares
-
Analysis of T cell hybridomas. IV. Characterization of inducible suppressor cell hybridomas
Publicado: (1983) -
How to make a hybridoma.
por: Lerner, E. A.
Publicado: (1981) -
Hybridoma technology: is it still useful?
por: Moraes, Jane Zveiter, et al.
Publicado: (2021) -
Hybridoma technology: new developments of practical interest
por: Samoilovich, Sergio R., et al.
Publicado: (1987) -
The application of hybridoma technology to the study of bovine immunoglobulins
por: Goldsby, R.A., et al.
Publicado: (1987)